220 related articles for article (PubMed ID: 15049696)
1. N-terminally extended surfactant protein (SP) C isolated from SP-B-deficient children has reduced surface activity and inhibited lipopolysaccharide binding.
Li J; Ikegami M; Na CL; Hamvas A; Espinassous Q; Chaby R; Nogee LM; Weaver TE; Johansson J
Biochemistry; 2004 Apr; 43(13):3891-8. PubMed ID: 15049696
[TBL] [Abstract][Full Text] [Related]
2. Structure and influence on stability and activity of the N-terminal propeptide part of lung surfactant protein C.
Li J; Liepinsh E; Almlén A; Thyberg J; Curstedt T; Jörnvall H; Johansson J
FEBS J; 2006 Mar; 273(5):926-35. PubMed ID: 16478467
[TBL] [Abstract][Full Text] [Related]
3. Inherited disorders of neonatal lung diseases.
Yurdakök M
Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic structural and functional determinants within the amino acid sequence of mature pulmonary surfactant protein SP-B.
Serrano AG; Cruz A; Rodríguez-Capote K; Possmayer F; Pérez-Gil J
Biochemistry; 2005 Jan; 44(1):417-30. PubMed ID: 15628884
[TBL] [Abstract][Full Text] [Related]
5. Regulation and function of pulmonary surfactant protein B.
Pryhuber GS
Mol Genet Metab; 1998 Aug; 64(4):217-28. PubMed ID: 9758711
[TBL] [Abstract][Full Text] [Related]
6. The TTF-1/TAP26 complex differentially modulates surfactant protein-B (SP-B) and -C (SP-C) promoters in lung cells.
Yang MC; Guo Y; Liu CC; Weissler JC; Yang YS
Biochem Biophys Res Commun; 2006 Jun; 344(2):484-90. PubMed ID: 16630564
[TBL] [Abstract][Full Text] [Related]
7. Mapping and analysis of the lytic and fusogenic domains of surfactant protein B.
Ryan MA; Qi X; Serrano AG; Ikegami M; Perez-Gil J; Johansson J; Weaver TE
Biochemistry; 2005 Jan; 44(3):861-72. PubMed ID: 15654742
[TBL] [Abstract][Full Text] [Related]
8. Partial deficiency of surfactant protein B in an infant with chronic lung disease.
Ballard PL; Nogee LM; Beers MF; Ballard RA; Planer BC; Polk L; deMello DE; Moxley MA; Longmore WJ
Pediatrics; 1995 Dec; 96(6):1046-52. PubMed ID: 7491219
[TBL] [Abstract][Full Text] [Related]
9. Compound SFTPB 1549C-->GAA (121ins2) and 457delC heterozygosity in severe congenital lung disease and surfactant protein B (SP-B) deficiency.
Tredano M; van Elburg RM; Kaspers AG; Zimmermann LJ; Houdayer C; Aymard P; Hull WM; Whitsett JA; Elion J; Griese M; Bahuau M
Hum Mutat; 1999; 14(6):502-9. PubMed ID: 10571948
[TBL] [Abstract][Full Text] [Related]
10. Inherited surfactant protein-B deficiency and surfactant protein-C associated disease: clinical features and evaluation.
Hamvas A
Semin Perinatol; 2006 Dec; 30(6):316-26. PubMed ID: 17142157
[TBL] [Abstract][Full Text] [Related]
11. Topographical organization of the N-terminal segment of lung pulmonary surfactant protein B (SP-B(1-25)) in phospholipid bilayers.
Wang Y; Rao KM; Demchuk E
Biochemistry; 2003 Apr; 42(14):4015-27. PubMed ID: 12680754
[TBL] [Abstract][Full Text] [Related]
12. Protein-lipid interactions and surface activity in the pulmonary surfactant system.
Serrano AG; Pérez-Gil J
Chem Phys Lipids; 2006 Jun; 141(1-2):105-18. PubMed ID: 16600200
[TBL] [Abstract][Full Text] [Related]
13. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.
Palmblad M; Johansson J; Robertson B; Curstedt T
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270
[TBL] [Abstract][Full Text] [Related]
14. Mutations linked to interstitial lung disease can abrogate anti-amyloid function of prosurfactant protein C.
Nerelius C; Martin E; Peng S; Gustafsson M; Nordling K; Weaver T; Johansson J
Biochem J; 2008 Dec; 416(2):201-9. PubMed ID: 18643778
[TBL] [Abstract][Full Text] [Related]
15. Lung specific developmental expression of the Xenopus laevis surfactant protein C and B genes.
Hyatt BA; Resnik ER; Johnson NS; Lohr JL; Cornfield DN
Gene Expr Patterns; 2007 Jan; 7(1-2):8-14. PubMed ID: 16798105
[TBL] [Abstract][Full Text] [Related]
16. Modification of tryptophan and methionine residues is implicated in the oxidative inactivation of surfactant protein B.
Manzanares D; Rodriguez-Capote K; Liu S; Haines T; Ramos Y; Zhao L; Doherty-Kirby A; Lajoie G; Possmayer F
Biochemistry; 2007 May; 46(18):5604-15. PubMed ID: 17425286
[TBL] [Abstract][Full Text] [Related]
17. [Surfactant-associated proteins B and C: molecular biology and physiologic properties].
Gortner L; Hilgendorff A
Z Geburtshilfe Neonatol; 2004 Jun; 208(3):91-7. PubMed ID: 15229816
[TBL] [Abstract][Full Text] [Related]
18. Membrane activity of (Cys48Ser) lung surfactant protein B increases with dimerisation.
Zaltash S; Griffiths WJ; Beck D; Duan CX; Weaver TE; Johansson J
Biol Chem; 2001 Jun; 382(6):933-9. PubMed ID: 11501758
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein B in type II pneumocytes and intra-alveolar surfactant forms of human lungs.
Brasch F; Johnen G; Winn-Brasch A; Guttentag SH; Schmiedl A; Kapp N; Suzuki Y; Müller KM; Richter J; Hawgood S; Ochs M
Am J Respir Cell Mol Biol; 2004 Apr; 30(4):449-58. PubMed ID: 12972403
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein B inhibits endotoxin-induced lung inflammation.
Epaud R; Ikegami M; Whitsett JA; Jobe AH; Weaver TE; Akinbi HT
Am J Respir Cell Mol Biol; 2003 Mar; 28(3):373-8. PubMed ID: 12594064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
